Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 16, 2009

Premium

Former National Institutes of Health Director Elias Zerhouni has joined the board of directors at Danaher. Zerhouni served as head of NIH between 2002 and 2008. During his tenure, he undertook the Roadmap for Medical Research, which aims to increase collaboration between NIH's 27 institutes and centers and to pursue innovative and important research areas. Zerhouni currently is a senior advisor at Johns Hopkins University School of Medicine and a senior fellow for the Bill and Melinda Gates Foundation's Global Health Program.


Affymetrix last week named Andrew Last to the position of chief commercial officer. Prior to joining Affymetrix, Last served on the leadership team of BD Biosciences' cell analysis unit, where he was vice president of global marketing and strategic planning and general manager of BD's San Diego-based Pharmingen business.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.